BCAM and visceral leishmaniasis: In this context, this article shows, for the first time, that Lu entrapped in nanostructured lipid carriers exhibited a potent and significant leishmanicidal activity in experimental visceral leishmaniasis compared to treatment performed only with Lu or AmB, suggesting that this formulation can be considered as an interesting alternative to conventional therapy.